• Info
  • Significant Ownership

Significant Ownership of Northpond Ventures III, LP

Signature - Title
/s/ Patrick Smerkers - By Northpond Ventures III GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Location
Bethesda, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Northpond Ventures III, LP.

Notify me when Northpond Ventures III, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Northpond Ventures III, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KYTX Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share 6.1% $28,531,978 3,466,826 Michael P. Rubin 31 Dec 2025

Schedules 13D/G Reported by Northpond Ventures III, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.